These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8193880)

  • 1. Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    Joshi JH; Newman KA; Brown BW; Finley RS; Ruxer RL; Moody MA; Schimpff SC
    Support Care Cancer; 1993 Jul; 1(4):186-94. PubMed ID: 8193880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
    Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
    Cometta A; Zinner S; de Bock R; Calandra T; Gaya H; Klastersky J; Langenaeken J; Paesmans M; Viscoli C; Glauser MP
    Antimicrob Agents Chemother; 1995 Feb; 39(2):445-52. PubMed ID: 7726513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone.
    Winston DJ; Ho WG; Bruckner DA; Champlin RE
    Ann Intern Med; 1991 Dec; 115(11):849-59. PubMed ID: 1952471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group.
    De Pauw BE; Deresinski SC; Feld R; Lane-Allman EF; Donnelly JP
    Ann Intern Med; 1994 May; 120(10):834-44. PubMed ID: 8154643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
    Marie JP; Marjanovic Z; Vekhoff A; Bouvet A; Chast F; Levy V; Baudard M; Legrand O; Rio B; Delmer A; Zittoun R
    Support Care Cancer; 1999 Mar; 7(2):89-94. PubMed ID: 10089089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program.
    Cometta A; Calandra T; Gaya H; Zinner SH; de Bock R; Del Favero A; Bucaneve G; Crokaert F; Kern WV; Klastersky J; Langenaeken I; Micozzi A; Padmos A; Paesmans M; Viscoli C; Glauser MP
    Antimicrob Agents Chemother; 1996 May; 40(5):1108-15. PubMed ID: 8723449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
    Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J
    Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
    Anaissie EJ; Fainstein V; Bodey GP; Rolston K; Elting L; Kantarjian H; Cabanillas F; McCredie KB
    Am J Med; 1988 Mar; 84(3 Pt 2):581-9. PubMed ID: 3279774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
    Peacock JE; Herrington DA; Wade JC; Lazarus HM; Reed MD; Sinclair JW; Haverstock DC; Kowalsky SF; Hurd DD; Cushing DA; Harman CP; Donowitz GR
    Ann Intern Med; 2002 Jul; 137(2):77-87. PubMed ID: 12118962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gram-negative bacteremia.
    Schimpff SC
    Support Care Cancer; 1993 Jan; 1(1):5-18. PubMed ID: 8143100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
    Ramphal R; Gucalp R; Rotstein C; Cimino M; Oblon D
    Am J Med; 1996 Jun; 100(6A):83S-89S. PubMed ID: 8678102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
    Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE
    Am J Med; 1988 Jul; 85(1A):21-30. PubMed ID: 3041815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
    Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    Wade JC; Schimpff SC; Newman KA; Fortner CL; Standiford HC; Wiernik PH
    Am J Med; 1981 Dec; 71(6):983-90. PubMed ID: 6459027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes.
    Todeschini G; Veneri D; Carlini S; Pizzolo G; Ambrosetti A; Bonesi R; Cassibba V; Vinante F; Meneghini V; Perona G
    Hematol Oncol; 1991; 9(3):137-46. PubMed ID: 1937406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients].
    Sampi K; Kumai R; Maseki N; Sakurai M; Kaneko Y; Hattori M
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):674-9. PubMed ID: 3469935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empiric antibiotic therapy for granulocytopenic cancer patients.
    Schimpff SC
    Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia.
    Nováková I; Donnelly P; De Pauw B
    Scand J Infect Dis; 1990; 22(6):705-11. PubMed ID: 2284577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective comparative trial of short course (four day) and continuous tobramycin in combination with cefoperazone or mezlocillin in febrile, granulocytopenic patients.
    Pegram PS; Phair JP; McMahan R; Murphy RL; Gordon LI; Washton H; Faubion C; Saviteer S; Cohen MS
    J Antimicrob Chemother; 1989 Oct; 24(4):591-604. PubMed ID: 2693432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.